20/20 Biolabs, Inc. - Common Stock (AIDX)

1.6400
-0.3500 (-17.59%)
NASDAQ · Last Trade: Mar 25th, 1:46 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
What's Going On With 20/20 Biolabs Stock?benzinga.com
Shares of 20/20 Biolabs, Inc. (NASDAQ: AIDX) are trading lower Tuesday after the company announced that it entered into an exclusive U.S. technology license and access agreement with ROKIT Healthcare.
Via Benzinga · March 24, 2026